CNTB - Company ID 0001835268
The table below shows Connect Biopharma Holdings Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $169.00K | $16.00K | $48.00K | $0.00 | $1.22M | $24.12M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $15.03M | $11.11M | $8.77M | $6.63M | $9.01M | $5.35M |
Connect Biopharma Holdings Ltd reported annual revenue of $64.00K for fiscal year 2025. That is down 99.8% from $26.03M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $4.75M |
| $6.58M |
| $4.70M |
| $4.81M |
| $6.06M |
| $5.12M |
| Operating income | -$19.61M | -$17.68M | -$13.42M | -$11.45M | -$13.85M | $13.65M |
| Income tax | $48.00K | $61.00K | $55.00K | $54.00K | $57.00K | $30.00K |
| Net income | -$19.40M | -$17.20M | -$12.90M | -$10.27M | -$12.88M | $14.85M |
| EPS (diluted) | -$0.34 | -$0.31 | -$0.23 | -$0.19 | -$0.23 | $0.27 |